Fjarde Ap-fonden’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-96,969
| Closed | -$5.25M | – | 506 |
|
|
2025
Q3 | $5.25M | Buy |
96,969
+700
| +0.7% | +$40K | 0.05% | 318 |
|
|
2025
Q2 | $5.29M | Buy |
96,269
+14,700
| +18% | +$866K | 0.05% | 321 |
|
|
2025
Q1 | $5.77M | Buy |
81,569
+4,300
| +6% | +$289K | 0.07% | 275 |
|
|
2024
Q4 | $5.08M | Buy |
77,269
+4,200
| +6% | +$281K | 0.05% | 337 |
|
|
2024
Q3 | $5.14M | Buy |
+73,069
| New | +$6.11M | 0.05% | 338 |
|
|
2024
Q1 | $5.51M | Buy |
63,069
+2,300
| +4% | +$206K | 0.06% | 325 |
|
|
2023
Q4 | $5.86M | Sell |
60,769
-11,400
| -16% | -$1.01M | 0.07% | 284 |
|
|
2023
Q3 | $6.39M | Buy |
72,169
+5,400
| +8% | +$480K | 0.08% | 250 |
|
|
2023
Q2 | $5.79M | Buy |
66,769
+800
| +1% | +$75.3K | 0.07% | 283 |
|
|
2023
Q1 | $6.41M | Buy |
65,969
+1,800
| +3% | +$187K | 0.09% | 260 |
|
|
2022
Q4 | $6.64M | Sell |
64,169
-13,700
| -18% | -$1.29M | 0.09% | 240 |
|
|
2022
Q3 | $6.45M | Hold |
77,869
| – | – | 0.08% | 256 |
|
|
2022
Q2 | $6.45M | Buy |
77,869
+12,500
| +19% | +$995K | 0.08% | 256 |
|
|
2022
Q1 | $5.04M | Sell |
65,369
-800
| -1% | -$66.9K | 0.05% | 387 |
|
|
2021
Q4 | $5.85M | Sell |
66,169
-2,800
| -4% | -$231K | 0.05% | 365 |
|
|
2021
Q3 | $5.33M | Sell |
68,969
-2,200
| -3% | -$174K | 0.05% | 379 |
|
|
2021
Q2 | $5.94M | Sell |
71,169
-5,800
| -8% | -$460K | 0.05% | 359 |
|
|
2021
Q1 | $5.81M | Buy |
76,969
+2,000
| +3% | +$163K | 0.05% | 362 |
|
|
2020
Q4 | $6.57M | Sell |
74,969
-1,400
| -2% | -$111K | 0.06% | 292 |
|
|
2020
Q3 | $5.81M | Buy |
76,369
+5,500
| +8% | +$556K | 0.06% | 293 |
|
|
2020
Q2 | $8.74M | Buy |
70,869
+4,400
| +7% | +$437K | 0.11% | 188 |
|
|
2020
Q1 | $5.62M | Buy |
66,469
+6,100
| +10% | +$526K | 0.09% | 217 |
|
|
2019
Q4 | $5.1M | Buy |
60,369
+8,300
| +16% | +$627K | 0.06% | 325 |
|
|
2019
Q3 | $3.51M | Buy |
52,069
+9,600
| +23% | +$739K | 0.05% | 416 |
|
|
2019
Q2 | $3.64M | Sell |
42,469
-13,400
| -24% | -$1.15M | 0.05% | 423 |
|
|
2019
Q1 | $4.96M | Buy |
55,869
+9,808
| +21% | +$909K | 0.06% | 321 |
|
|
2018
Q4 | $3.92M | Sell |
46,061
-10,200
| -18% | -$970K | 0.07% | 288 |
|
|
2018
Q3 | $5.46M | Sell |
56,261
-979
| -2% | -$97.7K | 0.08% | 262 |
|
|
2018
Q2 | $5.39M | Buy |
57,240
+2,550
| +5% | +$223K | 0.08% | 268 |
|
|
2018
Q1 | $4.43M | Sell |
54,690
-1,900
| -3% | -$163K | 0.07% | 319 |
|
|
2017
Q4 | $5.05M | Buy |
56,590
+7,720
| +16% | +$671K | 0.08% | 277 |
|
|
2017
Q3 | $4.55M | Sell |
48,870
-854
| -2% | -$75.5K | 0.09% | 257 |
|
|
2017
Q2 | $4.52M | Buy |
49,724
+5,904
| +13% | +$537K | 0.09% | 246 |
|
|
2017
Q1 | $3.85M | Sell |
43,820
-3,122
| -7% | -$278K | 0.09% | 247 |
|
|
2016
Q4 | $3.89M | Sell |
46,942
-1,631
| -3% | -$140K | 0.09% | 252 |
|
|
2016
Q3 | $4.49M | Buy |
48,573
+573
| +1% | +$54K | 0.1% | 237 |
|
|
2016
Q2 | $3.73M | Sell |
48,000
-1,697
| -3% | -$144K | 0.09% | 266 |
|
|
2016
Q1 | $4.1M | Buy |
49,697
+4,307
| +9% | +$350K | 0.09% | 242 |
|
|
2015
Q4 | $4.76M | Buy |
45,390
+1,275
| +3% | +$133K | 0.13% | 180 |
|
|
2015
Q3 | $4.65M | Sell |
44,115
-600
| -1% | -$80.1K | 0.13% | 180 |
|
|
2015
Q2 | $6.12M | Sell |
44,715
-1,601
| -3% | -$198K | 0.15% | 160 |
|
|
2015
Q1 | $5.77M | Hold |
46,316
| – | – | 0.13% | 180 |
|
|
2014
Q4 | $4.19M | Hold |
46,316
| – | – | 0.09% | 262 |
|
|
2014
Q3 | $3.34M | Sell |
46,316
-3,809
| -8% | -$250K | 0.07% | 321 |
|
|
2014
Q2 | $3.12M | Hold |
50,125
| – | – | 0.06% | 375 |
|
|
2014
Q1 | $3.42M | Buy |
50,125
+1,476
| +3% | +$109K | 0.07% | 337 |
|
|
2013
Q4 | $3.42M | Sell |
48,649
-1,852
| -4% | -$126K | 0.07% | 329 |
|
|
2013
Q3 | $3.65M | Buy |
50,501
+2,223
| +5% | +$148K | 0.08% | 312 |
|
|
2013
Q2 | $2.69M | Buy |
+48,278
| New | +$3.01M | 0.06% | 410 |
|
Other funds holding BMRN
